Myriad Genetics’ third quarter saw revenue and adjusted profit in line with Wall Street expectations, but the market reacted negatively due to ongoing challenges in average revenue per test and ...
Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
Direct to consumer genetic health tests are popular but is taking one a good idea? We brought in genetics counselor Karin Dent to explain the realities of at-home genetics testing and why it’s ...
For diseases like depression, finding medications that work well for patients can be a long, arduous journey. Genetic tests now claim to speed it along by giving doctors more information about how ...
Genetics testing company 23andMe can now tell you about your breast cancer risk — at least based on three mutations found on the BRCA1 and BRCA2 genes. Genetic counselors who help people navigate ...
The introduction of new genetic tests, like other medical innovations, can be conceptualized as a three-step process. Tests are proposed for use based on research findings and clinical reasoning; an ...
Myriad Genetics’ first quarter results were met with a significant negative market reaction, reflecting investor concerns over a combination of volume softness in key product lines and a reset in full ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results